ATE458039T1 - Menschliche hepatomazellinien, deren gewinung und deren verwendungen - Google Patents

Menschliche hepatomazellinien, deren gewinung und deren verwendungen

Info

Publication number
ATE458039T1
ATE458039T1 AT02764950T AT02764950T ATE458039T1 AT E458039 T1 ATE458039 T1 AT E458039T1 AT 02764950 T AT02764950 T AT 02764950T AT 02764950 T AT02764950 T AT 02764950T AT E458039 T1 ATE458039 T1 AT E458039T1
Authority
AT
Austria
Prior art keywords
cells
hepatotropic
cell lines
hepatoma cell
human hepatoma
Prior art date
Application number
AT02764950T
Other languages
English (en)
Inventor
Philippe Gripon
Sylvie Rumin
Christiane Guguen-Guillouzo
Christian Trepo
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE458039T1 publication Critical patent/ATE458039T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Light Receiving Elements (AREA)
  • Luminescent Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT02764950T 2001-07-06 2002-07-08 Menschliche hepatomazellinien, deren gewinung und deren verwendungen ATE458039T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0109044 2001-07-06
PCT/FR2002/002391 WO2003004627A2 (fr) 2001-07-06 2002-07-08 Lignees d'hepatomes humains leurs optentions et leurs applications

Publications (1)

Publication Number Publication Date
ATE458039T1 true ATE458039T1 (de) 2010-03-15

Family

ID=8865245

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02764950T ATE458039T1 (de) 2001-07-06 2002-07-08 Menschliche hepatomazellinien, deren gewinung und deren verwendungen

Country Status (9)

Country Link
US (1) US7456018B2 (de)
EP (2) EP2180041A3 (de)
JP (1) JP4711381B2 (de)
AT (1) ATE458039T1 (de)
CA (1) CA2453100C (de)
DE (1) DE60235366D1 (de)
DK (1) DK1404816T3 (de)
ES (1) ES2342050T3 (de)
WO (1) WO2003004627A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781186B2 (en) * 2000-09-25 2010-08-24 The United States Of America As Represented By The Secretary Of The Army Screening methods using normal human liver cell line
GB2403403B (en) * 2003-06-24 2006-07-19 Smiths Group Plc Vacuum cleaner with suction-retractable hose
US7687619B2 (en) 2004-02-05 2010-03-30 Millipore Corporation Room temperature stable agarose solutions
EP2421954B1 (de) * 2009-04-21 2018-12-26 Academisch Ziekenhuis bij de Universiteit van Amsterdam Differenzierte menschenleberzellenkulturen und deren verwendung in bioartifiziellen lebersystemen
CN103124787B (zh) * 2010-10-05 2015-04-29 宝生物工程株式会社 制造病毒载体的方法
JP6014119B2 (ja) 2012-03-22 2016-10-25 タカラバイオ株式会社 ウイルスベクターの製造方法
WO2013146480A1 (ja) * 2012-03-29 2013-10-03 タカラバイオ株式会社 遺伝子導入方法
EP2890779B1 (de) 2012-08-31 2017-10-04 The Governors of the University of Alberta Verfahren zur herstellung von zellen mit einem phänotyp primärer menschlicher hepatozyten und zusammensetzungen
CN103087989A (zh) * 2013-02-01 2013-05-08 湖南省肿瘤医院 一种人肝癌细胞系hlcz01及其应用
US11066649B2 (en) 2014-03-19 2021-07-20 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for inducing human cholangiocyte differentiation
US10292382B2 (en) 2014-04-03 2019-05-21 Biopredic International Sarl No-spin cryopreservation technique and resulting products
EP3183573B1 (de) 2014-08-22 2021-04-14 Biopredic International Mechanische veränderungen der gallencanaliculi-aktivität und des rho-kinase-myosin-ii-pfads und modulation der junktionalen permeabilität, verfahren zur detektion und verwendung von derivaten davon
US9765300B2 (en) 2014-12-10 2017-09-19 Biopredic International Hepatic cell lines and stem-like cells, methods of making and using the same
JP6644395B2 (ja) * 2015-02-05 2020-02-12 公益財団法人ヒューマンサイエンス振興財団 正常ヒト肝細胞のアンモニア除去能の向上方法
WO2016185281A1 (en) 2015-05-20 2016-11-24 Biopredic International New hepatic cell lines and methods of making and using the same
US12590296B2 (en) 2019-11-15 2026-03-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Method of culturing immortalized human hepatic progenitors or cells
CN111440769B (zh) * 2020-02-25 2021-07-06 浙江大学 一种人肝细胞性肝癌细胞株及其应用
KR20230010625A (ko) 2020-03-11 2023-01-19 비트 바이오 리미티드 간 세포 생성 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393133A (en) 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US5595909A (en) 1988-05-23 1997-01-21 Regents Of The University Of Minnesota Filter device
KR950703640A (ko) * 1992-10-09 1995-09-20 가일 케이,나우톤. 간 보존 세포(liver reserve cells)
US5804441A (en) 1995-11-09 1998-09-08 Kirin Beer Kabushiki Kaisha Human hepatoma-derived cell line FLC-4 and method for producing useful polymers by culturing the cell line
EP0972828A1 (de) * 1998-06-24 2000-01-19 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verfahren zur in vitro Replikation von HCV

Also Published As

Publication number Publication date
JP2004535809A (ja) 2004-12-02
US20050064594A1 (en) 2005-03-24
WO2003004627A2 (fr) 2003-01-16
EP2180041A2 (de) 2010-04-28
DE60235366D1 (de) 2010-04-01
CA2453100A1 (fr) 2003-01-16
EP1404816B1 (de) 2010-02-17
CA2453100C (fr) 2013-10-29
JP4711381B2 (ja) 2011-06-29
ES2342050T3 (es) 2010-07-01
WO2003004627A3 (fr) 2003-09-25
WO2003004627B1 (fr) 2003-11-20
EP1404816A2 (de) 2004-04-07
EP2180041A3 (de) 2010-05-26
DK1404816T3 (da) 2010-06-07
US7456018B2 (en) 2008-11-25

Similar Documents

Publication Publication Date Title
DE60235366D1 (de) Menschliche hepatomazellinien, deren gewinung und deren verwendungen
Lanford et al. Advances in model systems for hepatitis C virus research
Pol et al. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users
Gehring et al. The level of viral antigen presented by hepatocytes influences CD8 T-cell function
Xu et al. Advances in HBV infection and replication systems in vitro
Yun et al. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors.
DK1043399T3 (da) Hepatitis C Virus cellekultursystem
Carloni et al. Susceptibility of human liver cell cultures to hepatitis C virus infection
JP2007518426A5 (de)
Gondeau et al. Cellular models for the screening and development of anti-hepatitis C virus agents
Hirschman Integrator enzyme hypothesis for replication of hepatitis-B virus
ATE362538T1 (de) Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
Serafino et al. Ultrastructural observations of viral particles within hepatitis C virus-infected human B lymphoblastoid cell line
Tong et al. Evaluation of sexual transmission in patients with chronic hepatitis C infection
JP6418761B2 (ja) 肝炎組織体、肝炎ウイルスの感染方法、肝炎組織体の製造方法、肝炎ウイルスの増殖方法、肝炎ワクチンの製造方法、スクリーニング方法、及びキット
WO2007039662B1 (es) Línea celular vero adaptada para crecer en suspensión, procedimiento para su obtención y vacunas virales
Lupberger et al. Cultivation of HepG2. 2.15 on Cytodex-3: higher yield of hepatitis B virus and less subviral particles compared to conventional culture methods
Lok et al. Assessing the virological response to direct-acting antiviral therapies in the HBV cure programme
Brass et al. Of mice and men: a small animal model of hepatitis C virus replication
Saeed et al. In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosis
ATE430167T1 (de) Humaner rekombinanter antikörper gegen das hepatitis c (hcv) nichtstrukturelles ns3 protein, nukleinsäure und deren verwendungen
Tennant Animal models of hepatitis B virus infection
ATE345814T1 (de) Herstellung eines chimeren papillomavirus
WO2002072776A3 (en) Cell culture system for synthesis of infectious hepatitis c virus
Woollard et al. O. 052 Detection of intrahepatic virus-specific T-cells in marmosets with resolved GBV-B infection

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties